Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingming Yu

Showing results (211-220 of 224) with videos related to

Pageof 23
Sort By:
Analytical Methods : Advancing Methods and Applications|August 20, 2025
Quantification and discovery of quality control chemical markers for Shouhui Tongbian capsules by UPLC-MS/MSJieting Zhang, Shuo Diao, Zhen Huang, et al.
Frontiers in Pharmacology|December 5, 2025
Metabolomic changes associated with treatment response of neoadjuvant chemotherapy with TEC regimen in HER2-negative breast cancerKun Fang, Cuiping Wang, Zhenfeng Li, et al.
Journal of Hazardous Materials|November 11, 2019
Prenatal low-dose DEHP exposure induces metabolic adaptation and obesity: Role of hepatic thiamine metabolismYun Fan, Yufeng Qin, Minjian Chen, et al.
Ebiomedicine|August 14, 2018
Integrated analysis of DNA methylome and transcriptome identified CREB5 as a novel risk gene contributing to recurrent pregnancy lossMingming Yu, Guizhen Du, Qiaoqiao Xu, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 10, 2026
Optimization of pediatric dosing regimens for aztreonam and amoxicillin/clavulanate combination therapy against multidrug-resistant bacteriaLili Wang, Mengyuan Wu, Lin Qu, et al.
Microbiology Spectrum|February 11, 2025
The impact of aztreonam-clavulanic acid exposure on gene expression and mutant selection using a multidrug-resistant <i>E. coli</i>Tongtong Lin, Jiayuan Zhang, Shuo Diao, et al.
Cancer Letters|February 16, 2024
CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progressionHaojie Chen, Keqin Dong, Jie Ding, et al.
Frontiers in Microbiology|December 9, 2022
The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant <i>Acinetobacter baumannii</i>Jiayuan Zhang, Shuo Diao, Yanfei Liu, et al.
Scientific Reports|June 1, 2021
Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapyNayara Helisandra Fedrigo, Danielle Rosani Shinohara, Josmar Mazucheli, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2021
Aztreonam/avibactam effect on pharmacodynamic indices for mutant selection of Escherichia coli and Klebsiella pneumoniae harbouring serine- and New Delhi metallo-β-lactamasesKun Feng, Nan Jia, Peijuan Zhu, et al.
Pageof 23

Showing results (211-220 of 224) with videos related to

Sort By:
Pageof 23
Analytical Methods : Advancing Methods and Applications|August 20, 2025
Quantification and discovery of quality control chemical markers for Shouhui Tongbian capsules by UPLC-MS/MSJieting Zhang, Shuo Diao, Zhen Huang, et al.
Frontiers in Pharmacology|December 5, 2025
Metabolomic changes associated with treatment response of neoadjuvant chemotherapy with TEC regimen in HER2-negative breast cancerKun Fang, Cuiping Wang, Zhenfeng Li, et al.
Journal of Hazardous Materials|November 11, 2019
Prenatal low-dose DEHP exposure induces metabolic adaptation and obesity: Role of hepatic thiamine metabolismYun Fan, Yufeng Qin, Minjian Chen, et al.
Ebiomedicine|August 14, 2018
Integrated analysis of DNA methylome and transcriptome identified CREB5 as a novel risk gene contributing to recurrent pregnancy lossMingming Yu, Guizhen Du, Qiaoqiao Xu, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 10, 2026
Optimization of pediatric dosing regimens for aztreonam and amoxicillin/clavulanate combination therapy against multidrug-resistant bacteriaLili Wang, Mengyuan Wu, Lin Qu, et al.
Microbiology Spectrum|February 11, 2025
The impact of aztreonam-clavulanic acid exposure on gene expression and mutant selection using a multidrug-resistant <i>E. coli</i>Tongtong Lin, Jiayuan Zhang, Shuo Diao, et al.
Cancer Letters|February 16, 2024
CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progressionHaojie Chen, Keqin Dong, Jie Ding, et al.
Frontiers in Microbiology|December 9, 2022
The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant <i>Acinetobacter baumannii</i>Jiayuan Zhang, Shuo Diao, Yanfei Liu, et al.
Scientific Reports|June 1, 2021
Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapyNayara Helisandra Fedrigo, Danielle Rosani Shinohara, Josmar Mazucheli, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2021
Aztreonam/avibactam effect on pharmacodynamic indices for mutant selection of Escherichia coli and Klebsiella pneumoniae harbouring serine- and New Delhi metallo-β-lactamasesKun Feng, Nan Jia, Peijuan Zhu, et al.
Pageof 23